Outset Medical Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $117.8M+3.6% YoYTTM through 30 Jun 2026
Net Income -$74.3MTTM through 30 Jun 2026
Free Cash Flow -$38.9MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 39.1% |
| EBITDA Margin | -53.2% |
| Operating Margin | -55.8% |
| Net Margin | -63.1% |
Returns
-77.1%ROE
-30.6%ROA
Balance Sheet Health
Debt / Equity0.76x
Current Ratio6.70x
Net Debt-$64.3Mnet cash position
Cash & Equivalents$35M
Quality Metrics
Altman Z-Score-6.23
Piotroski F-Score4 / 9
FCF Margin-33.0%
Rule of 40-26.3
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $119.5M
Diluted EPS-$3.80TTMFY2025: $-5,368.00
Dividend
No dividend
Capital Allocation
R&D Spend$21.5M
Capex Intensity0.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Product | $84.8M | +5.0% | |
| Service and other | $34.7M | +6.0% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.